InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by MURPHY WILLIAM P JR, Director. Officer active across 1 company, notably U.S. Stem Cell, Inc.. In total, 9 disclosures have been published. Activity tracked since 23 March 2021. The latest transaction was filed on 23 March 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
7,518,797 shares@ US$0.026650.0% of flowCommon StockSEC:0001185185-21-001028
7,518,797 shares@ US$0.026650.0% of flowCommon StockSEC:0001185185-21-001028:0
14,606 sharesCommon StockSEC:0001185185-16-003718:0
219,155 sharesCommon StockSEC:0001185185-16-003483:0
55,056 sharesCommon StockSEC:0001185185-16-003483:1
2,150 sharesCommon StockSEC:0001185185-16-003406:0
900 sharesCommon StockSEC:0001185185-16-003406:1
1,850 sharesCommon StockSEC:0001185185-16-003406:2
300 sharesCommon StockSEC:0001185185-16-003406:3
9 of 9 declarations
About MURPHY WILLIAM P JR
William P. Murphy Jr. serves as a Director at U.S. Stem Cell, Inc. As a board member, he contributes to the strategic direction of the company and oversees its activities. William brings valuable experience in the stem cell sector, enabling him to assess growth and innovation opportunities. His role is crucial in ensuring compliance and transparency in governance.
